Midatech Pharma plc (MTP)
After hours:
| Previous Close | 0.7400 |
| Open | 0.7400 |
| Bid | 0.0000 x 1800 |
| Ask | 0.0000 x 1100 |
| Day's Range | 0.7100 - 0.7400 |
| 52 Week Range | 0.3800 - 1.9200 |
| Volume | |
| Avg. Volume | 212,196 |
| Market Cap | 14.575M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4150 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
Orphan Designation Granted by EMA to MTX110 Development for the Treatment of GliomaABINGDON, NR / ACCESSWIRE / June 21, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that following the submission of an application to the European Medicines Agency ("EMA"), its development programme of MTX110 for the treatment of glioma has been granted Orphan Medicinal Product designa
- ACCESSWIRE
Midatech Pharma PLC Announces Directorate Change
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce the appointment of Dr Stephen Parker as a Director of the Company and Non-Executive Chairman of the Board with immediate effect.
- ACCESSWIRE
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces that Rolf Stahel, Chairman and non-executive director, intends to retire after the Company's Annual General Meeting on 20 June 2022 ("AGM").
